Down-regulated RBPs |
Cellular Component |
U2-type spliceosomal complex |
2.07E-08 |
6.09E-06 |
Spliceosomal snRNP complex |
4.95E-07 |
9.51E-05 |
U2-type prespliceosome |
5.67E-07 |
9.51E-05 |
Prespliceosome |
5.67E-07 |
9.51E-05 |
U1 snRNP |
3.68E-09 |
1.44E-06 |
Molecular Function |
RNA binding |
0 |
0 |
mRNA binding |
5.81E-9 |
5.45E-6 |
snRNA binding |
4.60E-5 |
2.88E-2 |
Biological Process |
Positive regulation of mRNA processing |
2.27E-05 |
1.15E-02 |
mRNA splice site selection |
2.06E-05 |
1.10E-02 |
Positive regulation of RNA splicing |
4.19E-07 |
4.23E-04 |
Positive regulation of mRNA splicing, via spliceosome |
7.14E-06 |
4.06E-03 |
Regulation of chaperone-mediated autophagy |
8.14E-05 |
3.89E-02 |
KEGG pathway |
Spliceosome |
3.19E-5 |
1.04E-2 |
Up-regulated RBPs |
Cellular Component |
U1 snRNP |
2.17E-12 |
1.06E-10 |
U4 snRNP |
2.81E-9 |
8.48E-8 |
U12-type spliceosomal complex |
1.33E-15 |
1.04E-13 |
Box H/ACA snoRNP complex |
3.73E-5 |
6.09E-4 |
Histone pre-mRNA 3ʹend processing complex |
5.43E-9 |
1.59E-7 |
Molecular Function |
RNA 7-methylguanosine cap binding |
1.50E-5 |
6.40E-4 |
Exoribonuclease activity, producing 5ʹ-phosphomonoesters |
6.66E-16 |
1.25E-13 |
Transforming growth factor beta receptor, pathway-specific cytoplasmic mediator |
6.62E-5 |
2.44E-3 |
Box H/ACA snoRNA binding |
6.62E-5 |
2.44E-3 |
snRNP binding |
4.30E-6 |
2.18E-4 |
Biological Process |
Ribosomal subunit export from nucleus |
1.59E-07 |
1.24E-05 |
Termination of RNA polymerase II transcription |
1.38E-14 |
1.90E-12 |
Positive regulation of cytoplasmic mRNA processing body assembly |
1.18E-04 |
4.84E-03 |
Regulation of ribonuclease activity |
2.40E-07 |
1.80E-05 |
mRNA cleavage involved in gene silencing |
5.97E-05 |
2.66E-03 |
KEGG pathway |
Aminoacyl-tRNA biosynthesis |
3.13E-8 |
1.70E-6 |
Ribosome biogenesis in eukaryotes |
0 |
0 |
RNA transport |
2.22E-16 |
2.41E-14 |
mRNA surveillance pathway |
5.33E-15 |
4.34E-13 |
RNA degradation |
6.75E-14 |
4.40E-12 |
Spliceosome |
0 |
0 |